Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Drug-Related Problems (DRP) are a variety of events or circumstances that can interfere with the expected results of a treatment. They may be due to the drug itself, its association with other treatments, its incompatibility with the patient, its misuse... When these situations result in harm, they are referred to as adverse drug events (ADEs). DRP and particularly ADE represent a major public health problem in healthcare institutions because of their impact on morbidity and health costs.
DRPs are largely preventable and actions can be set up to detect and correct them. It is in this context that clinical pharmacy has expanded, with the development of new activities to help secure drug management. In our institution, the investigators have implemented several activities in different care services, including
In this study, the investigators seek to identify DRP risk factors and develop DRP risk scores, with the objective to improve the detection and even prevention of DRP.
Translated with www.DeepL.com/Translator (free version)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with an Adverse Drug Events or Drug-Related Problems | Patients with an Adverse Drug Events or Drug-Related Problems |
| |
| Patients without an Adverse Drug Events or Drug-Related Problems | Patients without an Adverse Drug Events or Drug-Related Problems |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Detection of Adverse Drug Events or Drug-Related Problems | Other | Detection of Adverse Drug Events or Drug-Related Problems |
|
| Measure | Description | Time Frame |
|---|---|---|
| Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems | Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Number and type of Adverse Drug Events and Drug-Related Problems | Number and type of Adverse Drug Events and Drug-Related Problems | 1 day |
Not provided
Inclusion criteria:
- Patients aged above 18 years old, admitted to the emergency department or hospital
Exclusion criteria:
Not provided
Not provided
Not provided
Study population was composed of patient admitted in emergency department or medical units of Montpellier University hospital.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cyril BREUKER, PharmD, PhD | University Hospital, Montpellier | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uhmontpellier | Montpellier | 34295 | France |
NC
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D004700 | Endocrine System Diseases |